OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats
Dong Ji, Nicholas W. Gilpin, Heather N. Richardson, et al.
Behavioural Pharmacology (2008) Vol. 19, Iss. 1, pp. 1-12
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Addiction and Brain Reward and Antireward Pathways
Eliot L. Gardner
Advances in psychosomatic medicine (2011), pp. 22-60
Open Access | Times Cited: 388

The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Sunmee Wee, George F. Koob
Psychopharmacology (2010) Vol. 210, Iss. 2, pp. 121-135
Open Access | Times Cited: 373

Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit Disorder
George F. Koob
Current topics in behavioral neurosciences (2011), pp. 3-30
Open Access | Times Cited: 308

Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit Disorder
George F. Koob
Current topics in behavioral neurosciences (2011), pp. 3-30
Closed Access | Times Cited: 294

The persistence of maladaptive memory: Addiction, drug memories and anti-relapse treatments
Amy Milton, Barry J. Everitt
Neuroscience & Biobehavioral Reviews (2012) Vol. 36, Iss. 4, pp. 1119-1139
Open Access | Times Cited: 254

“Drinking in the dark” (DID) procedures: A model of binge-like ethanol drinking in non-dependent mice
Todd E. Thiele, Montserrat Navarro
Alcohol (2013) Vol. 48, Iss. 3, pp. 235-241
Open Access | Times Cited: 237

Neurocircuitry of alcohol addiction
George F. Koob
Handbook of clinical neurology (2014), pp. 33-54
Closed Access | Times Cited: 205

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 78

Neurobiology of alcohol dependence: focus on motivational mechanisms.
Nicholas W. Gilpin, George F. Koob
PubMed (2008)
Closed Access | Times Cited: 230

Preclinical studies of alcohol binge drinking
John C. Crabbe, R. Adron Harris, George F. Koob
Annals of the New York Academy of Sciences (2011) Vol. 1216, Iss. 1, pp. 24-40
Open Access | Times Cited: 212

Don’t stress about CRF: assessing the translational failures of CRF1antagonists
Samantha R. Spierling, Eric P. Zorrilla
Psychopharmacology (2017) Vol. 234, Iss. 9-10, pp. 1467-1481
Open Access | Times Cited: 153

Neurobiology of comorbid post‐traumatic stress disorder and alcohol‐use disorder
Nicholas W. Gilpin, Jeffrey L. Weiner
Genes Brain & Behavior (2016) Vol. 16, Iss. 1, pp. 15-43
Open Access | Times Cited: 139

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
George F. Koob, Eric P. Zorrilla
PubMed (2010) Vol. 11, Iss. 1, pp. 63-71
Closed Access | Times Cited: 135

CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis
Emily G. Lowery, Marina Spanos, Montserrat Navarro, et al.
Neuropsychopharmacology (2010) Vol. 35, Iss. 6, pp. 1241-1252
Open Access | Times Cited: 133

Neurotransmitters in alcoholism: A review of neurobiological and genetic studies
Niladri Banerjee
Indian journal of human genetics (2014) Vol. 20, Iss. 1, pp. 20-20
Open Access | Times Cited: 116

Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Mehdi Farokhnia, Monica L. Faulkner, Daria Piacentino, et al.
Physiology & Behavior (2019) Vol. 204, pp. 49-57
Closed Access | Times Cited: 96

Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86

Alcohol, stress hormones, and the prefrontal cortex: A proposed pathway to the dark side of addiction
Yi-Ling Lu, Heather N. Richardson
Neuroscience (2014) Vol. 277, pp. 139-151
Open Access | Times Cited: 74

Ethanol Intake Under Social Circumstances or Alone inSprague–Dawley Rats: Impact of Age, Sex, Social Activity, and Social Anxiety‐Like Behavior
Elena I. Varlinskaya, Eric Truxell, Linda P. Spear
Alcoholism Clinical and Experimental Research (2015) Vol. 39, Iss. 1, pp. 117-125
Open Access | Times Cited: 68

Chronic intermittent ethanol exposure during adolescence: Effects on stress-induced social alterations and social drinking in adulthood
Elena I. Varlinskaya, Esther U. Kim, Linda P. Spear
Brain Research (2016) Vol. 1654, pp. 145-156
Open Access | Times Cited: 62

Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies
Scott Edwards, Leandro F. Vendruscolo, Nicholas W. Gilpin, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 2, pp. 368-383
Open Access | Times Cited: 54

Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder
George F. Koob, Leandro F. Vendruscolo
Current topics in behavioral neurosciences (2023)
Closed Access | Times Cited: 16

MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
Hila Richardson, Y ZHAO, É.M. Fekete, et al.
Pharmacology Biochemistry and Behavior (2007) Vol. 88, Iss. 4, pp. 497-510
Open Access | Times Cited: 95

Page 1 - Next Page

Scroll to top